177 related articles for article (PubMed ID: 30349922)
1. Differentiating breast cancer molecular subtypes using a DNA aptamer selected against MCF-7 cells.
Liu M; Yang T; Chen Z; Wang Z; He N
Biomater Sci; 2018 Nov; 6(12):3152-3159. PubMed ID: 30349922
[TBL] [Abstract][Full Text] [Related]
2. An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer.
Liu M; Wang Z; Tan T; Chen Z; Mou X; Yu X; Deng Y; Lu G; He N
Theranostics; 2018; 8(20):5772-5783. PubMed ID: 30555580
[TBL] [Abstract][Full Text] [Related]
3. In vitro selection of aptamer S1 against MCF-7 human breast cancer cells.
Zhang WY; Chen HL; Chen QC
Bioorg Med Chem Lett; 2019 Aug; 29(16):2393-2397. PubMed ID: 31196711
[TBL] [Abstract][Full Text] [Related]
4. Identification of PHB2 as a Potential Biomarker of Luminal A Breast Cancer Cells Using a Cell-Specific Aptamer.
Liu M; Wang Z; Li S; Deng Y; He N
ACS Appl Mater Interfaces; 2022 Nov; 14(46):51593-51601. PubMed ID: 36346944
[TBL] [Abstract][Full Text] [Related]
5. Precise discrimination of Luminal A breast cancer subtype using an aptamer in vitro and in vivo.
Liu M; Zhang B; Li Z; Wang Z; Li S; Liu H; Deng Y; He N
Nanoscale; 2020 Oct; 12(38):19689-19701. PubMed ID: 32966497
[TBL] [Abstract][Full Text] [Related]
6. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J
Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016
[TBL] [Abstract][Full Text] [Related]
7. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
8. An on-chip Cell-SELEX process for automatic selection of high-affinity aptamers specific to different histologically classified ovarian cancer cells.
Hung LY; Wang CH; Hsu KF; Chou CY; Lee GB
Lab Chip; 2014 Oct; 14(20):4017-28. PubMed ID: 25144781
[TBL] [Abstract][Full Text] [Related]
9. A truncated DNA aptamer with high selectivity for estrogen receptor-positive breast cancer cells.
Cong Y; Zhang SY; Li HM; Zhong JJ; Zhao W; Tang YJ
Int J Biol Macromol; 2023 Dec; 252():126450. PubMed ID: 37634779
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Selection of a DNA Aptamer by Cell-SELEX as a Molecular Probe for Cervical Cancer Recognition and Imaging.
Wang J; Gao T; Luo Y; Wang Z; Zhang Y; Zhang Y; Zhang Y; Pei R
J Mol Evol; 2019 Apr; 87(2-3):72-82. PubMed ID: 30659315
[TBL] [Abstract][Full Text] [Related]
11. Development of a CD63 Aptamer for Efficient Cancer Immunochemistry and Immunoaffinity-Based Exosome Isolation.
Song Z; Mao J; Barrero RA; Wang P; Zhang F; Wang T
Molecules; 2020 Nov; 25(23):. PubMed ID: 33261145
[TBL] [Abstract][Full Text] [Related]
12. A cell-based single-stranded DNA aptamer specifically targets gastric cancer.
Zhang X; Zhang J; Ma Y; Pei X; Liu Q; Lu B; Jin L; Wang J; Liu J
Int J Biochem Cell Biol; 2014 Jan; 46():1-8. PubMed ID: 24501772
[TBL] [Abstract][Full Text] [Related]
13. Selection and characterization of novel DNA aptamer against colorectal carcinoma Caco-2 cells.
Maimaitiyiming Y; Yang C; Wang Y; Hussain L; Naranmandura H
Biotechnol Appl Biochem; 2019 May; 66(3):412-418. PubMed ID: 30746785
[TBL] [Abstract][Full Text] [Related]
14. Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.
Rong Y; Chen H; Zhou XF; Yin CQ; Wang BC; Peng CW; Liu SP; Wang FB
Oncotarget; 2016 Feb; 7(7):8282-94. PubMed ID: 26882565
[TBL] [Abstract][Full Text] [Related]
15. Development of a ssDNA aptamer for detection of residual benzylpenicillin.
Lee AY; Ha NR; Jung IP; Kim SH; Kim AR; Yoon MY
Anal Biochem; 2017 Aug; 531():1-7. PubMed ID: 28522308
[TBL] [Abstract][Full Text] [Related]
16. SELEX methods on the road to protein targeting with nucleic acid aptamers.
Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
[TBL] [Abstract][Full Text] [Related]
17. In vitro selection of a DNA aptamer targeted against Shigella dysenteriae.
Duan N; Ding X; Wu S; Xia Y; Ma X; Wang Z; Chen J
J Microbiol Methods; 2013 Sep; 94(3):170-4. PubMed ID: 23811206
[TBL] [Abstract][Full Text] [Related]
18. Systematic evaluation of cell-SELEX enriched aptamers binding to breast cancer cells.
Civit L; Taghdisi SM; Jonczyk A; Haßel SK; Gröber C; Blank M; Stunden HJ; Beyer M; Schultze J; Latz E; Mayer G
Biochimie; 2018 Feb; 145():53-62. PubMed ID: 29054799
[TBL] [Abstract][Full Text] [Related]
19. A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer.
Speransky S; Serafini P; Caroli J; Bicciato S; Lippman ME; Bishopric NH
Breast Cancer Res Treat; 2019 Jul; 176(2):271-289. PubMed ID: 31006104
[TBL] [Abstract][Full Text] [Related]
20. In vitro selection of DNA aptamers for metastatic breast cancer cell recognition and tissue imaging.
Li X; Zhang W; Liu L; Zhu Z; Ouyang G; An Y; Zhao C; Yang CJ
Anal Chem; 2014 Jul; 86(13):6596-603. PubMed ID: 24892693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
